International Journal of Life science and Pharma Reviews (IJLPR)  
   
  Aim and Scope - To publish peer reviewed review articles in rapidly developing field of Pharma and life sciences  
 
Article
Pharmaceutical Sciences
Volume 12 Issue 3, May 2022    Pages:24-28
Creating Awareness of Deadly Cytokine Storm to Common People and A Self Case Study

R. Baskaran, Ajay Rajasekaran B, A. M. Nithiya, And A.M. Aparna
[View PDF]
DOI: http://dx.doi.org/10.22376/ijpbs/lpr.2022.12.3.P24-28
Abstract:
This review with case study covers the severity and hidden symptoms of cytokine storm that were missed in other articles. Most of the review studies focus on cytokine storm in a random way but this paper creates awareness to common people so that the intensity of the disease spreading can be minimized and fatality can be prevented. Cytokine storm is an umbrella term encompassing several disorders of immune disregulation. The symptoms, properties, mechanism and treatment methods for cytokine storm have been discussed along with preventive methods. Details about silent hypoxemia and its effects were also highlighted which are a major reason for not detecting this disease at early stages. This paper also describes a case of life-threatening cytokine storm caused by COVID-19 infection that was treated with clonal antibody and suppressed the cytokine release.  This paper also highlights the importance of Vitamin D level in a body, which can suppress cytokines production by simultaneously boosting the innate immune system. Lesson learnt from this disease are elderly patients, especially males, with comorbidities, demonstrate increased susceptibility to poor prognosis or increased risk of severe condition or even fatality from COVID-19. Reports indicate that men appear to suffer more severe cases and die of the disease at greater rates than women, with deaths possibly up to 20 percent higher. This issue leads to future research and can work on the methods to increase the immunity of men to reach at least the immunity level of women so that fatality rate can be minimized. It has been concluded that if covid is left untreated, the cytokine starts releasing from the body and progress to extensive tissue damage, organ failure, and death.
Keywords: COVID-19, Cytokine Storm, SARS-CoV-2, Immune Disregulation, Hypoxemia
Full HTML:

1.      Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. (2020) 46:846–8.

2.       Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020)

3.       Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci  (1893)105:487-511.

4.       Behrens E, Kreiger P, Cherian S, Cron R. Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis. J Rheumatol. (2006) 33:2081–4.

5.       Nirav Nimavat , Shruti Singh, Pratibha Singh, Sunil Kumar Singh , Nishi Sinha, Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India, Ann Med Surg (Lond)68(2021)102661

6.       David C. Fajgenbaum, and Carl H. June Cytokine Storm N Engl J Med 2020; 383:2255-2273

7.       M. B. Atkins, M. T. Lotze, J. P. Dutcher et al., “High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993,” Journal of Clinical Oncology, vol. 17, no. 7, pp. 2105–2116, (1999).

8.       C. A. Dinarello, A. Simon, and J. W. M. van der Meer, “Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases,” Nature Reviews Drug Discovery, vol. 11, no. 8, pp. 633–652,( 2012)

9.       Sylvester Chibueze Izah , Saket Singh Chandel, Ayobami Omozemoje Aigberua , T. Venkatachalam and Deepshikha Verma Coronavirus Disease 2019: The  Emergence of Popular Unverified Myths and Realities  Spread, 2020.10.5.P17-26

10.     Qing Ye, Bili Wang, and Jianhua Mao? The pathogenesis and treatment of the `Cytokine Storm' in COVID-19, J Infect 2020 Jun; 80(6): 607–613.

11.     R.Baskaran, Rajinikanth, Ajay Rajasekaran, A deep learning system to classify lung xray images in to normal pneumonia class, Journal of Infectious diseases, Vol.101,pp 201 (2020)

12.     Lee N, Allen Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol. (2004);31(4):304-309.

13.     Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. (2020) ;395:473-475.      

14.     Laura, Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey, Journal of translational medicine., 18, 229 (2020). 

15.     R.Baskaran, Antoinette B,Toxicities and tolerances of the cancer cervix patients,Asian Journal of Pharmaceutical  and Research 4 (1), 40-43 (2011)

16.     R.Baskaran, Antoinette B,  Review on rapid arc based stereotactic body radio surgery for lung, Head and neck cancer, (2012) Asian Journal of pharmaceutical and clinical Research 5 (1), 5-6

17.     Rimjhim Singh , Neha Bothra , Murali Mohan Challa And Prameela Kandra A review on covid-19: From molecular variability, drug development to status of vaccine clinical trials, International Journal of Life science and Pharma Research (IJLPR) Volume 12 issue 1, January pp:55-71

18.     . Nimila Elsa Mathews, Paramita Sengupta, Anoop Ivan Benjamin, Indian Journal of public health,  Effect of vitamin-D supplementation on self-perceived health-related quality of life in postmenopausal women in Ludhiana, Punjab  (2021)   65 ,3  294-297

19.     Mario Luciano de Mélo Silva Júnior, Review on  therapeutic targets for COVID-19: insights from   cytokine storm, Post graduate medical Journal,  Volume 97, Issue 1148

20.     Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020) 395:507–13

21.     21.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054–62.

22.     Jae Seok Kim, Jun Young Lee, Jae Won Yang, immunopathogenesis and treatment of cytokine storm in covid -19, Theranostics, 2021; 11(1):316-329.

23.     Srikanth Medimpudi, Lucklin Medimpudi and Lakshmana Rao Ayyagari, Impact of Covid-19 on the Buying Behaviour of Consumers with Respect to Purchase of Medicines Through online and Retail Outlets, , International Journal of Life science and Pharma Research (IJLPR), Volume 11 issue 5, September 2021 pp:30-40

24.     Wilson F Abdo, Catharina I, Broerse Bart P, Prolonged unconsciousness following severe Covid 19, American Acadamy of Neurology, vol 96,10, 2020

 
© 2010-2015 IJLPR rights reserved. Specialized onine journals by ubijournal. Website by Ubitech Solutions